pyruvic acid has been researched along with Atrophy in 13 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of microneedling with 15% trichloroacetic acid (TCA) peel versus microneedling with 25% pyruvic acid peel in the management of postacne scars." | 9.69 | Microneedling in Combination With 15% Trichloroacetic Acid Peel Versus 25% Pyruvic Acid Peel in the Treatment of Acne Scars. ( Choudhary, P; Relhan, V; Sahoo, B; Sarkar, R; Solanki, B, 2023) |
| "The effects of treatment with indole-pyruvic acid, an endogenous metabolite of tryptophan converted into kynurenic acid in the brain, were studied in rats after transient forebrain ischemia induced by the 4-vessel occlusion procedure." | 7.68 | Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat. ( Agnati, LF; Biagini, G; Ferraguti, F; Fuxe, K; Merlo Pich, E; Zoli, M, 1993) |
| "To compare the efficacy of microneedling with 15% trichloroacetic acid (TCA) peel versus microneedling with 25% pyruvic acid peel in the management of postacne scars." | 5.69 | Microneedling in Combination With 15% Trichloroacetic Acid Peel Versus 25% Pyruvic Acid Peel in the Treatment of Acne Scars. ( Choudhary, P; Relhan, V; Sahoo, B; Sarkar, R; Solanki, B, 2023) |
| "Clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) resemble those of cerebral infarcts, but the pathogenesis of infarct-like lesions is not fully understood." | 3.70 | Serial diffusion-weighted imaging in MELAS. ( Imon, Y; Kajima, T; Katayama, S; Mimori, Y; Nakamura, S; Ohshita, T; Oka, M; Watanabe, C; Yamaguchi, S, 2000) |
| "The effects of treatment with indole-pyruvic acid, an endogenous metabolite of tryptophan converted into kynurenic acid in the brain, were studied in rats after transient forebrain ischemia induced by the 4-vessel occlusion procedure." | 3.68 | Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat. ( Agnati, LF; Biagini, G; Ferraguti, F; Fuxe, K; Merlo Pich, E; Zoli, M, 1993) |
| "Alpers syndrome is a progressive encephalopathy of early onset, characterized by rapid and severe developmental delay, intractable seizures and liver involvement in a previously healthy child." | 1.31 | Respiratory chain deficiency in Alpers syndrome. ( Chrétien, D; Cormier-Daire, V; de Lonlay, P; Gauthier-Villars, M; Jacquemin, E; Landrieu, P; Munnich, A; Rötig, A; Rustin, P, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraki, N | 1 |
| Tanaka, TD | 1 |
| Yoshimura, M | 1 |
| Solanki, B | 1 |
| Relhan, V | 1 |
| Sahoo, B | 1 |
| Sarkar, R | 1 |
| Choudhary, P | 1 |
| Sharma, U | 1 |
| Upadhyay, D | 1 |
| Mewar, S | 1 |
| Mishra, A | 1 |
| Das, P | 1 |
| Gupta, SD | 1 |
| Dwivedi, SN | 1 |
| Makharia, GK | 1 |
| Jagannathan, NR | 1 |
| Marcoux, J | 1 |
| McArthur, DA | 1 |
| Miller, C | 1 |
| Glenn, TC | 1 |
| Villablanca, P | 1 |
| Martin, NA | 1 |
| Hovda, DA | 1 |
| Alger, JR | 1 |
| Vespa, PM | 1 |
| HEYCK, H | 1 |
| Prick, MJ | 1 |
| Gabreëls, FJ | 2 |
| Trijbels, JM | 1 |
| Janssen, AJ | 1 |
| le Coultre, R | 1 |
| van Dam, K | 1 |
| Jaspar, HH | 1 |
| Ebels, EJ | 1 |
| Op de Coul, AA | 1 |
| Odessey, R | 1 |
| Parr, B | 1 |
| Zoli, M | 1 |
| Merlo Pich, E | 1 |
| Ferraguti, F | 1 |
| Biagini, G | 1 |
| Fuxe, K | 1 |
| Agnati, LF | 1 |
| Bakker, HD | 1 |
| Van den Bogert, C | 1 |
| Drewes, JG | 1 |
| Barth, PG | 1 |
| Scholte, HR | 1 |
| Wanders, RJ | 1 |
| Ruitenbeek, W | 2 |
| Ohshita, T | 1 |
| Oka, M | 1 |
| Imon, Y | 1 |
| Watanabe, C | 1 |
| Katayama, S | 1 |
| Yamaguchi, S | 1 |
| Kajima, T | 1 |
| Mimori, Y | 1 |
| Nakamura, S | 1 |
| Giordano, G | 1 |
| Corradi, D | 1 |
| D'Adda, T | 1 |
| Melissari, M | 1 |
| Gauthier-Villars, M | 1 |
| Landrieu, P | 1 |
| Cormier-Daire, V | 1 |
| Jacquemin, E | 1 |
| Chrétien, D | 1 |
| Rötig, A | 1 |
| Rustin, P | 1 |
| Munnich, A | 1 |
| de Lonlay, P | 1 |
| van Erven, PM | 1 |
| Renier, WO | 1 |
| Thijssen, HO | 1 |
| Horstink, MW | 1 |
1 trial available for pyruvic acid and Atrophy
| Article | Year |
|---|---|
Microneedling in Combination With 15% Trichloroacetic Acid Peel Versus 25% Pyruvic Acid Peel in the Treatment of Acne Scars.
Topics: Acne Vulgaris; Atrophy; Cicatrix; Humans; Patient Satisfaction; Pyruvic Acid; Treatment Outcome; Tri | 2023 |
12 other studies available for pyruvic acid and Atrophy
| Article | Year |
|---|---|
A Man With Left Ventricular Hypertrophy.
Topics: Adult; Atrophy; Cardiomyopathies; Cerebellar Diseases; Cognitive Dysfunction; Echocardiography; Gluc | 2022 |
Metabolic abnormalities of gastrointestinal mucosa in celiac disease: An in vitro proton nuclear magnetic resonance spectroscopy study.
Topics: Adolescent; Adult; Amino Acids; Aspartic Acid; Atrophy; Biomarkers; Celiac Disease; Citric Acid Cycl | 2015 |
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury.
Topics: Adolescent; Adult; Atrophy; Biomarkers; Brain Diseases; Brain Injuries; Chronic Disease; Cohort Stud | 2008 |
[On the problem of cryptogenetic processes of brain atrophy: quantitative measurements of cerebral circulation and cerebral glucose, lactic acid and pyruvic acid metabolism].
Topics: Atrophy; Brain; Brain Diseases; Cerebrovascular Circulation; Glucose; Humans; Lactates; Lactic Acid; | 1961 |
Progressive poliodystrophy (Alpers' disease) with a defect in cytochrome aa3 in muscle: a report of two unrelated patients.
Topics: Atrophy; Brain; Child; Child, Preschool; Cytochrome a Group; Cytochrome-c Oxidase Deficiency; Cytoch | 1983 |
Effect of insulin and leucine on protein turnover in rat soleus muscle after burn injury.
Topics: Adenosine Triphosphate; Animals; Atrophy; Burns; Insulin; Lactates; Lactic Acid; Leucine; Male; Musc | 1982 |
Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat.
Topics: Animals; Atrophy; Brain Ischemia; Cell Survival; Corpus Striatum; Dopamine and cAMP-Regulated Phosph | 1993 |
Progressive generalized brain atrophy and infantile spasms associated with cytochrome c oxidase deficiency.
Topics: Acidosis; Atrophy; Brain; Cytochrome-c Oxidase Deficiency; Humans; Infant, Newborn; Lactates; Lactic | 1996 |
Serial diffusion-weighted imaging in MELAS.
Topics: Adult; Atrophy; Brain; DNA, Mitochondrial; Echo-Planar Imaging; Female; Humans; Lactic Acid; Magneti | 2000 |
[An autopsy case of neonatal lactic acidosis].
Topics: Acidosis, Lactic; Atrophy; Autopsy; Body Fluids; Brain; Cardiomegaly; Epilepsy, Generalized; Fatal O | 2001 |
Respiratory chain deficiency in Alpers syndrome.
Topics: Atrophy; Biopsy, Needle; Cerebral Cortex; Child, Preschool; Consanguinity; Diagnosis, Differential; | 2001 |
Hypokinesia and rigidity as clinical manifestations of mitochondrial encephalomyopathy: report of three cases.
Topics: Adolescent; Atrophy; Brain; Brain Diseases, Metabolic; Child; Child Development; Follow-Up Studies; | 1989 |